Manufacturer record
Paradox Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Paradox Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality in May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PZD242206, Pantoprazole Gastro resistant &Domperidone prolonged release Capsules IP (exp Dec 2026). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: Identification and Assay of Pantoprazole Sodium calculated as Pantoprazole and Domperidone and the Dissolution of Pantoprazole Sodium. Listed in the May 2025 alert.
Records by type
4 records linked to Paradox Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro resistant &Domperidone prolonged release Capsules IP | Batch PZD242206Mfg Jan 2025 · Exp Dec 2026 | Identification and Assay of Pantoprazole Sodium calculated as Pantoprazole and Domperidone and the Dissolution of Pantoprazole Sodium calculated as Pantoprazle.Assay | RDTL, ChandigarhCDSCO lab | May 2025 |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | Batch Not mentionedMfg ? · Exp ? | Identification, Dissolution and Assay of Azithromycin Dihydrate Calculated as Anhydrous AzithromycinAssay | RDTL, ChandigarhCDSCO lab | May 2025 |
| Azithromycin Tablets IP 250 mg (RICK-250 TABLETS) | Batch AZR2411010Mfg Jan 2025 · Exp Dec 2026 | Identification, Dissolution and the Assay of AzithromycinAssay | RDTL, ChandigarhCDSCO lab | May 2025 |
| Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (Polo-625 LB Tablets) | Batch PL2406001Mfg Oct 2024 · Exp Nov 2026 | Identification and Assay of Amoxycillin Trihydrate, Potassium Clavulanate and Lactic Acid BacillusAssay | RDTL, ChandigarhCDSCO lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.